Across TCGA pan-cancer cohorts, SCGB1D5P RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of SCGB1D5P’s most consistent transcriptional readouts.
The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where SCGB1D5P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types SCGB1D5P is over-expressed in tumor.
KIRC are the cancer types where SCGB1D5P tumor–normal differential expression is most reproducible.